Hypersensitivity to gadolinium-based contrast.

Abstract

PURPOSE OF REVIEW:

The use of contrast media is increasing in recent decades. Although gadolinium-based contrast agents (GBCAs) are generally well tolerated, adverse reactions, including hypersensitivity reactions (HSRs), although infrequent, may occur. It is important to perform a thorough allergological evaluation in patients with suspected GBCA-HSRs to avoid potentially serious reactions in subsequent exposures.

RECENT FINDINGS:

Data on GBCA-HSRs are scarce. Most published articles dealing with skin tests and drug provocation tests (DPTs) with GBCAs are case series and small cohorts. Controversies exist about the role of premedication for preventing HSRs on subsequent exposures. Selection of well tolerated alternatives is based on potential cross-reactivity among GBCAs; however, the extent of cross-reactivity among them remains unclear.

SUMMARY:

As premedication is not useful because breakthrough reactions are frequent in patients with GBCA-HSRs in subsequent exposures, an allergological evaluation is required. Available data suggest a high negative predictive value of skin tests, being crucial for guiding the selection of an alternative GBCA. However, DPTs are still necessary to confirm or exclude the diagnosis or find alternative GBCAs. Cross-reactivity is high among GBCAs belonging from the same group, mainly among macrocyclic compounds, so this must be taken into account for selecting alternatives.

• Authors: Rocío Sáenz de Santa María, Marina Labella, Gádor Bogas, Inmaculada Doña, María José Torres
• Journal: Current opinion in allergy and clinical immunology (Curr Opin Allergy Clin Immunol) Vol. 23 Issue 4 Pg. 300-306 (08 01 2023) ISSN: 1473-6322 [Electronic] United States
• PMID: 37357781 (Publication Type: Review, Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Chemical References

• Gadolinium
• diphenylthiosulfinate
• Contrast Media

Topics

• Humans
• Gadolinium (adverse effects)
• Drug Hypersensitivity (prevention & control)
• Contrast Media (adverse effects)
• Hypersensitivity (diagnosis, complications)